These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30944690)

  • 21. Significant association between Taq1 gene polymorphism in vitamin D receptor and chronic spontaneous urticaria in the Northeast of Iran.
    Khoshkhui M; Iravani F; Jabbari-Azad F; Zare Marzouni H; Tavakkol-Afshari J; Zamani H; Davarpanah M; Hamidian Jahromi A; Mohammadi M
    Clin Mol Allergy; 2021 May; 19(1):6. PubMed ID: 34044815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-Life Experience of Efficacy and Safety of Bilastine in the Refractory Cases of Chronic Spontaneous Urticaria and its Effect on the Quality of Life of Patients.
    De A; Godse K; Dhoot D; Sarda A
    Indian J Dermatol; 2021; 66(2):159-164. PubMed ID: 34188271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data.
    Salman A; Demir G; Bekiroglu N
    Dermatol Ther; 2019 Jul; 32(4):e12975. PubMed ID: 31145524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amelioration of patients with chronic spontaneous urticaria in treatment with vitamin D supplement.
    Ariaee N; Zarei S; Mohamadi M; Jabbari F
    Clin Mol Allergy; 2017; 15():22. PubMed ID: 29299028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is vitamin D concentration an indicator of the severity of atopic dermatitis and chronic spontaneous urticaria in adults?
    Jaworek AK; Obtułowicz A; Hałubiec P; Krzysztofik E; Wojas-Pelc A
    Pol Merkur Lekarski; 2020 Jun; 48(285):166-169. PubMed ID: 32564040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous serum and plasma skin test to predict 2-year outcome in chronic spontaneous urticaria.
    Boonpiyathad T; Sangasapaviliya A
    Asia Pac Allergy; 2016 Oct; 6(4):226-235. PubMed ID: 27803883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria.
    Finlay AY; Kaplan AP; Beck LA; Antonova EN; Balp MM; Zazzali J; Khalil S; Maurer M
    J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1715-1721. PubMed ID: 28573683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria.
    Metz M; Bernstein JA; Giménez-Arnau AM; Hide M; Maurer M; Sitz K; Soong W; Sussman G; Hua E; Barve A; Barbier N; Balp MM; Severin T
    World Allergy Organ J; 2022 Nov; 15(11):100716. PubMed ID: 36440464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rupatadine in Established Treatment Schemes Improves Chronic Spontaneous Urticaria Symptoms and Patients' Quality of Life: a Prospective, Non-interventional Trial.
    Metz M; Weller K; Neumeister C; Izquierdo I; Bödeker RH; Schwantes U; Maurer M
    Dermatol Ther (Heidelb); 2015 Dec; 5(4):217-230. PubMed ID: 26591001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omalizumab in Chronic Spontaneous Urticaria Refractory to Conventional Therapy: An Italian Retrospective Clinical Analysis with Suggestions for Long-Term Maintenance Strategies.
    Mandel VD; Guanti MB; Liberati S; Demonte A; Pellacani G; Pepe P
    Dermatol Ther (Heidelb); 2018 Jun; 8(2):291-301. PubMed ID: 29770909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between vitamin D and chronic spontaneous urticaria: a systematic review.
    Tuchinda P; Kulthanan K; Chularojanamontri L; Arunkajohnsak S; Sriussadaporn S
    Clin Transl Allergy; 2018; 8():51. PubMed ID: 30534360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased platelet activating factor levels in chronic spontaneous urticaria predicts refractoriness to antihistamine treatment: an observational study.
    Ulambayar B; Yang EM; Cha HY; Shin YS; Park HS; Ye YM
    Clin Transl Allergy; 2019; 9():33. PubMed ID: 31346408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study).
    Jauregui I; Gimenez-Arnau A; Bartra J; Labrador-Horrillo M; de Frutos JO; Silvestre JF; Sastre J; Velasco M; Ferrer M; Ballesteros C; Valero A
    Health Qual Life Outcomes; 2019 Jan; 17(1):23. PubMed ID: 30704532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective case note review of chronic spontaneous urticaria outcomes and adverse effects in patients treated with omalizumab or ciclosporin in UK secondary care.
    Savic S; Marsland A; McKay D; Ardern-Jones MR; Leslie T; Somenzi O; Baldock L; Grattan C
    Allergy Asthma Clin Immunol; 2015; 11(1):21. PubMed ID: 26195984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience.
    Nettis E; Cegolon L; Di Leo E; Canonica WG; Detoraki A;
    Ann Allergy Asthma Immunol; 2018 Mar; 120(3):318-323. PubMed ID: 29508719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of vitamin D add-on therapy on the improvement of quality of life and clinical symptoms of patients with chronic spontaneous urticaria.
    Nabavizadeh SH; Alyasin S; Esmaeilzadeh H; Mosavat F; Ebrahimi N
    Asian Pac J Allergy Immunol; 2023 Jun; 41(2):150-157. PubMed ID: 32828116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic urticaria in the real-life clinical practice setting in Sweden, Norway and Denmark: baseline results from the non-interventional multicentre AWARE study.
    Thomsen SF; Pritzier EC; Anderson CD; Vaugelade-Baust N; Dodge R; Dahlborn AK; Vestergaard C
    J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):1048-1055. PubMed ID: 28294420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of chronic inducible urticaria according to the guidelines: A prospective controlled study.
    Kocatürk E; Can PK; Akbas PE; Copur M; Degirmentepe EN; Kızıltac K; Singer R
    J Dermatol Sci; 2017 Jul; 87(1):60-69. PubMed ID: 28314658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of urticaria activity score in chronic spontaneous urticaria with serum C-reactive protein level and neutrophil/lymphocyte ratio.
    Akca HM; Tuncer Kara K
    Dermatol Ther; 2020 Nov; 33(6):e14532. PubMed ID: 33176046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria.
    Kolkhir P; Altrichter S; Hawro T; Maurer M
    Allergy; 2018 Apr; 73(4):940-948. PubMed ID: 29130488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.